Kai; Hirofumi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kai; Hirofumi.The latest application filed is for "evaluation system for therapeutic drug for genetic kidney disorder alport syndrome".

Company Profile

2.4.11

Kai; Hirofumi - Kumamoto JP
KAI; Hirofumi - Tokyo JP
Kai; Hirofumi - Chiyoda-ku JP
Kai; Hirofumi - Kumamoto-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Device for suppressing inflammation and hyperimmunity, and method for suppressing inflammation and hyperimmunity Grant 11,135,425 - Kai , et al. October 5, 2	2021-10-05
Evaluation System for Therapeutic Drug for Genetic Kidney Disorder Alport Syndrome App 20200172956 - KAI; HIROFUMI ; et al.	2020-06-04
Program Creating Device App 20190121816 - SASAKI; Kenichi ; et al.	2019-04-25
Device For Suppressing Inflammation And Hyperimmunity, And Method For Suppressing Inflammation And Hyperimmunity App 20190022384 - KAI; Hirofumi ; et al.	2019-01-24
Program creation support device Grant 8,843,885 - Nakai , et al. September 23, 2	2014-09-23
Sequence Program Creating Apparatus App 20130104101 - Yamaoka; Takayuki ; et al.	2013-04-25
Program Creation Support Device App 20120222001 - Nakai; Satoru ; et al.	2012-08-30
Ladder Program Edition Device App 20110295388 - Iwata; Hideaki ; et al.	2011-12-01
Medicine for prevention of and treatment for amyloidosis App 20060134228 - Kai; Hirofumi ; et al.	2006-06-22
GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same App 20060024728 - Kai; Hirofumi ; et al.	2006-02-02
Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same App 20050260582 - Kai, Hirofumi ; et al.	2005-11-24
Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same App 20040171122 - Kai, Hirofumi ; et al.	2004-09-02
Method for treating immune complex diseases with n-acetylneuraminic acid Grant 5,177,062 - Miyata , et al. January 5, 1	1993-01-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.